COST-EFFECTIVENESS OF DAPTOMYCIN IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND BACTEREMIA CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN TURKEY

被引：0
|
作者：
Pala, M. [1 ]
Gol, D. [1 ]
机构：
[1] Novartis Turkey, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73301-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A550 / A550
页数：1
相关论文
共 50 条
  • [41] Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
    Marty, FM
    Yeh, WW
    Wennersten, CB
    Venkataraman, L
    Albano, E
    Alyea, EP
    Gold, HS
    Baden, LR
    Pillai, SK
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) : 595 - 597
  • [42] Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: Teicoplanin versus vancomycin in a retrospective study
    Huang, Jih-Hsin
    Hsu, Ron-Bin
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (6-7) : 462 - 467
  • [43] Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia
    Cortes-Penfield, Nicolas
    Oliver, Nora T.
    Hunter, Andrew
    Rodriguez-Barradas, Maria
    INFECTIOUS DISEASES, 2018, 50 (08) : 643 - 647
  • [44] Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Bacteremia with the Addition of Rifampin to Daptomycin
    Ahmad, Nasir M.
    Rojtman, Albert D.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 918 - 921
  • [45] STAPHYLOCOCCUS AUREUS BACTEREMIA: FACTORS ASSOCIATED WITH INFECTIVE ENDOCARDITIS
    Le Moing, V.
    Alla, F.
    Doco-Lecompte, T.
    Delahaye, F.
    Piroth, L.
    Chirouze, C.
    Tattevin, P.
    Lavigne, J. -P.
    Vandenesch, F.
    Duval, X.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 : S8 - S8
  • [46] Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
    Bergin, Stephen P.
    Holland, Thomas L.
    Fowler, Vance G., Jr.
    Tong, Steven Y. C.
    STAPHYLOCOCCUS AUREUS: MICROBIOLOGY, PATHOLOGY, IMMUNOLOGY, THERAPY AND PROPHYLAXIS, 2017, 409 : 263 - 296
  • [47] Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus
    Tattevin, P.
    Basuino, L.
    Bauer, D.
    Diep, B. A.
    Chambers, H. F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) : 610 - 613
  • [48] Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
    Vu, Michelle
    Smith, Kenneth J.
    Aspinall, Sherrie L.
    Clancy, Cornelius J.
    Buehrle, Deanna J.
    CLINICAL DRUG INVESTIGATION, 2021, 41 (10) : 885 - 894
  • [49] Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
    Michelle Vu
    Kenneth J. Smith
    Sherrie L. Aspinall
    Cornelius J. Clancy
    Deanna J. Buehrle
    Clinical Drug Investigation, 2021, 41 : 885 - 894
  • [50] COST-EFFECTIVENESS STUDY OF THE USE OF DAPTOMYCIN VERSUS VANCOMYCIN IN INFECTIVE ENDOCARDITIS AND BACTEREMIA TREATMENT IN PUBLIC HEALTH INSTITUTIONS IN MEXICO
    Soria-Cedillo, I. F.
    Baca-Muro, V., I
    De la Mora-Chavez, T.
    Jirash, J.
    Garcia-Contreras, F.
    VALUE IN HEALTH, 2009, 12 (07) : A427 - A427
12345